# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-20-005753
Filing Date
2020-08-07
Accepted
2020-08-07 18:52:47
Documents
54
Period of Report
2020-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | bcrx20200630_10q.htm iXBRL | 10-Q | 1349964
2 | EXHIBIT 10.3 | ex_196806.htm | EX-10.3 | 1891
3 | EXHIBIT 31.1 | ex_196626.htm | EX-31.1 | 13183
4 | EXHIBIT 31.2 | ex_196627.htm | EX-31.2 | 13659
5 | EXHIBIT 32.1 | ex_196628.htm | EX-32.1 | 5261
6 | EXHIBIT 32.2 | ex_196629.htm | EX-32.2 | 4760
12 |  | exh103_1.jpg | GRAPHIC | 188473
13 |  | exh103_2.jpg | GRAPHIC | 62775
| Complete submission text file | 0001171843-20-005753.txt |  | 6419379

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA | bcrx-20200630.xsd | EX-101.SCH | 50949
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | bcrx-20200630_cal.xml | EX-101.CAL | 34266
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | bcrx-20200630_def.xml | EX-101.DEF | 376930
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | bcrx-20200630_lab.xml | EX-101.LAB | 360494
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | bcrx-20200630_pre.xml | EX-101.PRE | 390145
14 | EXTRACTED XBRL INSTANCE DOCUMENT | bcrx20200630_10q_htm.xml | XML | 957748

Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 201085971
SIC: 2836 Biological Products, (No Diagnostic Substances)